Hyperammonemia reduces ADAM17 in the membrane by increasing PKC activity, as supported by the fact that inhibition of PKC normalizes the levels in the membrane of both ADAM17 and TNFR1. The gene discussed is TNFRSF1A; the disease is Hyperammonemia.